Literature DB >> 26171127

The Prevalence of Magnetic Resonance Imaging Hyperintensity in Migraine Patients and Its Association with Migraine Headache Characteristics and Cardiovascular Risk Factors.

Mansoureh Toghae1, Elham Rahimian2, Mohammad Abdollahi3, Saeed Shoar4, Mohammad Naderan5.   

Abstract

OBJECTIVES: To determine the frequency of hyperintense foci in migraine patients and the relationship with migraine headache characteristics and cardiovascular risk factors.
METHODS: Ninety patients with migraine headache (70 without aura and 20 with aura) were enrolled and interviewed. Information on their headache (severity, frequency, and mean disease duration) and other related data was obtained by completing a clinical checklist. Subsequently, brain magnetic resonance imaging (MRI) was performed and each patient was then evaluated for hyperintense lesions.
RESULTS: Of the 90 patients, 29 (32%) had silent hyperintense lesions on their MRI. The mean age of the patients with hyperintense foci was 41 years while those with no lesions was 33 years (p<0.010). Supratentorial hyperintense lesions represented the majority of lesions in the patients (n=46, 63%). Moreover, 56.3% of the lesions (n=41) were located within the right hemisphere. Cardiovascular risk factors such as smoking, serum cholesterol, oral contraceptive pills use, and body mass index (BMI) were not significantly different in these two groups (p>0.050). The lesions were found significantly more frequently in the patients who experienced chronic migraine (p=0.032).
CONCLUSION: Our study adds weight to the theory that disease duration has a key role in the formation of hyperintense brain lesions. Certain cardiovascular risk factors such as sex, smoking, serum cholesterol, and BMI, do not affect the presence or absence of such lesions, suggesting that the relationship between migraine and these lesions may be directly due to the effects of migraine itself.

Entities:  

Keywords:  Magnetic Resonance Imaging; Migraine Disorders; Migraine with Aura; Migraine without Aura; White Matter

Year:  2015        PMID: 26171127      PMCID: PMC4459160          DOI: 10.5001/omj.2015.42

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  40 in total

1.  Anatomical variants of the circle of willis and brain lesions in migraineurs.

Authors:  C Cavestro; L Richetta; M R L'episcopo; E Pedemonte; S Duca; C Di Pietrantonj
Journal:  Can J Neurol Sci       Date:  2011-05       Impact factor: 2.104

2.  Migraine as a systemic disorder.

Authors:  Gretchen E Tietjen
Journal:  Neurology       Date:  2007-05-08       Impact factor: 9.910

Review 3.  Silent brain infarcts: a review of MRI diagnostic criteria.

Authors:  Yi-Cheng Zhu; Carole Dufouil; Christophe Tzourio; Hugues Chabriat
Journal:  Stroke       Date:  2011-03-10       Impact factor: 7.914

Review 4.  MRI findings in migraine.

Authors:  M C Kruit; L J Launer; M A van Buchem; G M Terwindt; M D Ferrari
Journal:  Rev Neurol (Paris)       Date:  2005-07       Impact factor: 2.607

Review 5.  Migraine and cardiovascular disease: systematic review and meta-analysis.

Authors:  Markus Schürks; Pamela M Rist; Marcelo E Bigal; Julie E Buring; Richard B Lipton; Tobias Kurth
Journal:  BMJ       Date:  2009-10-27

6.  MRI in migraineurs.

Authors:  L Robbins; H Friedman
Journal:  Headache       Date:  1992-11       Impact factor: 5.887

7.  Cerebrovascular risk factors and MRI abnormalities in migraine.

Authors:  Renata Rao; Anna Rosati; Paolo Liberini; Stefano Gipponi; Elisabetta Venturelli; Eluisa Sapia; Claudia Ambrosi; Alessandro Padovani
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

Review 8.  Mitochondrial dysfunction and migraine: evidence and hypotheses.

Authors:  M Sparaco; M Feleppa; R B Lipton; A M Rapoport; M E Bigal
Journal:  Cephalalgia       Date:  2006-04       Impact factor: 6.292

9.  Silent Cerebral Infarct Transfusion (SIT) trial imaging core: application of novel imaging information technology for rapid and central review of MRI of the brain.

Authors:  Bruce A Vendt; Robert C McKinstry; William S Ball; Michael A Kraut; Fred W Prior; Bruce Barton; James F Casella; Michael R DeBaun
Journal:  J Digit Imaging       Date:  2008-04-09       Impact factor: 4.056

10.  Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus.

Authors:  C Jongen; J van der Grond; L J Kappelle; G J Biessels; M A Viergever; J P W Pluim
Journal:  Diabetologia       Date:  2007-05-11       Impact factor: 10.122

View more
  5 in total

1.  Hypertension and Migraine in the Northern Manhattan Study.

Authors:  Hannah Gardener; Teshamae Monteith; Tatjana Rundek; Clinton B Wright; Mitchell S V Elkind; Ralph L Sacco
Journal:  Ethn Dis       Date:  2016-07-21       Impact factor: 1.847

2.  Relation between migraine pattern and white matter hyperintensities in brain magnetic resonance imaging.

Authors:  Mohamed Negm; Ahmed Mohamed Housseini; Mohamed Abdelfatah; Alshimaa Asran
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2018-09-10

Review 3.  From transformation to chronification of migraine: pathophysiological and clinical aspects.

Authors:  M Torres-Ferrús; F Ursitti; A Alpuente; F Brunello; D Chiappino; T de Vries; S Di Marco; S Ferlisi; L Guerritore; N Gonzalez-Garcia; A Gonzalez-Martinez; D Khutorov; M Kritsilis; A Kyrou; T Makeeva; A Minguez-Olaondo; L Pilati; A Serrien; O Tsurkalenko; D Van den Abbeele; W S van Hoogstraten; C Lampl
Journal:  J Headache Pain       Date:  2020-04-29       Impact factor: 7.277

4.  Risk factors of white matter hyperintensities in migraine patients.

Authors:  Jasem Yousef Al-Hashel; Raed Alroughani; Khaled Gad; Lamiaa Al-Sarraf; Samar Farouk Ahmed
Journal:  BMC Neurol       Date:  2022-04-29       Impact factor: 2.903

5.  Association of white matter hyperintensities with migraine features and prognosis.

Authors:  Hui Xie; Qiang Zhang; Kang Huo; Rui Liu; Zhi-Jie Jian; Yi-Tong Bian; Guo-Liang Li; Dan Zhu; Li-Hui Zhang; Jian Yang; Guo-Gang Luo
Journal:  BMC Neurol       Date:  2018-07-02       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.